Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 Stocks Estimated To Be Trading At Up To 49.2% Below Intrinsic Value

In This Article:

As global markets rally with major indices reaching new highs, driven by optimism over potential trade deals and AI investments, investors are keenly observing the performance of growth stocks, which have recently outpaced their value counterparts. Amidst this buoyant environment, identifying undervalued stocks can be a strategic move for those looking to capitalize on discrepancies between market price and intrinsic value. Recognizing such opportunities often involves assessing a company's fundamentals against prevailing market conditions to determine its true worth.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Argan (NYSE:AGX)

US$137.36

US$273.30

49.7%

Subros (BSE:517168)

₹600.55

₹1197.01

49.8%

Guangdong Mingyang ElectricLtd (SZSE:301291)

CN¥50.90

CN¥101.57

49.9%

74Software (ENXTPA:74SW)

€26.50

€52.89

49.9%

Solum (KOSE:A248070)

₩18950.00

₩37756.10

49.8%

Dynavox Group (OM:DYVOX)

SEK68.20

SEK136.07

49.9%

GemPharmatech (SHSE:688046)

CN¥13.06

CN¥26.02

49.8%

Shandong Weigao Orthopaedic Device (SHSE:688161)

CN¥25.57

CN¥51.06

49.9%

St. James's Place (LSE:STJ)

£9.31

£18.53

49.8%

Netum Group Oyj (HLSE:NETUM)

€2.82

€5.63

49.9%

Click here to see the full list of 899 stocks from our Undervalued Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

MicroPort NeuroScientific

Overview: MicroPort NeuroScientific Corporation focuses on the research, development, production, and sale of neuro-interventional medical devices both in China and internationally, with a market cap of HK$5.91 billion.

Operations: The company generates revenue of CN¥774.66 million from its surgical and medical equipment segment.

Estimated Discount To Fair Value: 49.2%

MicroPort NeuroScientific is trading at HK$10.24, significantly below its estimated fair value of HK$20.15, suggesting undervaluation based on cash flows. The company forecasts robust revenue growth of 21.4% annually, outpacing the Hong Kong market's 7.6%. Recent guidance indicates a net profit increase of up to 100% for 2024, driven by expanded hospital coverage and improved overseas revenue. However, its Return on Equity is expected to be modest at 14.5% in three years.

SEHK:2172 Discounted Cash Flow as at Jan 2025
SEHK:2172 Discounted Cash Flow as at Jan 2025

TORIDOLL Holdings

Overview: TORIDOLL Holdings Corporation operates and manages restaurants in Japan and internationally, with a market cap of ¥325.03 billion.